Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 2,000 DCOY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Decoy Therapeutics Inc. (DCOY) | Grant/Award | 2,000 | n/a |
| Feb 22, 2024 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 20,500 | n/a |
| Jan 5, 2023 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 1,440 | n/a |
| Jun 8, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 27,700 | $5.0K |
| Jan 21, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 30,000 | n/a |
| Dec 4, 2020 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 30,000 | n/a |
| Mar 25, 2020 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 6,000 | n/a |
| Feb 14, 2020 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 4,350 | $43.50 |
| Feb 13, 2020 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 4,350 | $5.0K |